Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 11 - 20 of about 143   

Articles published

GSK 1,671.10 -3.90 (-0.23%)
price chart
4 Shares With Dividend Yields Above 4%: GlaxoSmithKline plc, Aviva plc, BP plc ...
GlaxoSmithKline plc (LON:GSK) (LSE:GSK.L) has a dividend yield of 4.74%. In my view, it has investment appeal due to its diverse operations.
Quarterly EPS Forecast Of GlaxoSmithKline PLC (NYSE:GSK) At $0.59
Berenberg Bank Raises GlaxoSmithKline plc (GSK) Price Target to GBX 1890  Chaffey Breeze
Stock Focus: Checking Levels on GlaxoSmithKline PLC (GSK)
Currently, the 14-day ADX for GlaxoSmithKline PLC (GSK) is 42.72. Generally speaking, an ADX value from 0-25 would indicate an absent or weak trend.
This announcement relates to a PDMR who elected to participate in the GlaxoSmithKline 2009 Deferred Annual Bonus Plan ('DABP') in respect of his bonus on a post-tax basis.
GlaxoSmithKline plc (LSE:GSK) Valuation By The Numbers
The ERP5 Rank is an investment tool that analysts use to discover undervalued companies. The ERP5 looks at the Price to Book ratio, Earnings Yield, ROIC and 5 year average ROIC.
Looking at the Numbers for GlaxoSmithKline PLC (GSK.L)
GlaxoSmithKline PLC (GSK.L)'s 14-day RSI is presently resting at 59.44, the 7-day is 45.09, and the 3-day is currently at 16.64.
Glaxo to Pay First Woman CEO Less, Cites Lack of Experience
Emma Walmsley, poised to take over as the first female chief executive officer of GlaxoSmithKline Plc, will earn about a quarter less than her predecessor Andrew Witty to reflect her lack of experience at the helm.
GlaxoSmithKline plc's (GSK) Sell Rating Reaffirmed at Societe Generale
GlaxoSmithKline plc logo Societe Generale reiterated their sell rating on shares of GlaxoSmithKline plc (LON:GSK) in a research report released on Thursday.
The GlaxoSmithKline plc (GSK) Earns “Sell” Rating from Societe Generale  Petro Global News 24
Liberum Initiated its coverage for GlaxoSmithKline plc (GSK)  StandardOracle
GlaxoSmithKline plc's (GSK) “Underperform” Rating Reaffirmed at BNP Paribas
GlaxoSmithKline plc logo BNP Paribas restated their underperform rating on shares of GlaxoSmithKline plc (LON:GSK) in a research report released on Wednesday.
The GlaxoSmithKline plc (GSK) Receives “Underperform” Rating from BNP ...  Petro Global News 24
GlaxoSmithKline plc (GSK) Receives “Underperform” Rating from BNP Paribas  Chaffey Breeze
Analyst Activity – Credit Suisse Group Reiterates Neutral on GlaxoSmithKline ...
Today, Credit Suisse Group reiterated its Neutral rating on GlaxoSmithKline plc (LON:GSK) with a price target of GBX 1,750.
GlaxoSmithKline plc (GSK) Receives Average Recommendation of “Hold” from ...  Chaffey Breeze
Reliable stocks in today's share market: GlaxoSmithKline plc (NYSE:GSK)  The News Journal
EPS Prediction At $0.59 For GlaxoSmithKline PLC (NYSE:GSK)
Lately, GlaxoSmithKline PLC (NYSE:GSK) posted EPS of $0.65 for the period ended 2016-12-31. The company can likely broadcast financial report on 2017-04-26.